BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16043746)

  • 1. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance.
    Cardellini M; Perego L; D'Adamo M; Marini MA; Procopio C; Hribal ML; Andreozzi F; Frontoni S; Giacomelli M; Paganelli M; Pontiroli AE; Lauro R; Folli F; Sesti G
    Diabetes Care; 2005 Aug; 28(8):2007-12. PubMed ID: 16043746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition changes after laparoscopic adjustable gastric banding: what is the role of -174G>C interleukin-6 promoter gene polymorphism in the therapeutic strategy?
    Di Renzo L; Carbonelli MG; Bianchi A; Iacopino L; Fiorito R; Di Daniele N; De Lorenzo A
    Int J Obes (Lond); 2012 Mar; 36(3):369-78. PubMed ID: 21730965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet.
    Sesti G; Perego L; Cardellini M; Andreozzi F; Ricasoli C; Vedani P; Guzzi V; Marchi M; Paganelli M; Ferla G; Pontiroli AE; Hribal ML; Folli F
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5064-9. PubMed ID: 15985484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight.
    Goyenechea E; Parra D; Martínez JA
    Metabolism; 2007 Dec; 56(12):1643-8. PubMed ID: 17998015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity.
    Kubaszek A; Pihlajamäki J; Punnonen K; Karhapää P; Vauhkonen I; Laakso M
    Diabetes; 2003 Feb; 52(2):558-61. PubMed ID: 12540635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of relationship between 174G_C promoter polymorphism of the IL-6 gene and indices of metabolic syndrome in non-obese healthy subjects.
    Tworowska-Bardzińska U; Kubicka E; Slezak R; Mielcarek M; Bednarek-Tupikowska G; Bolanowski M; Milewicz A
    Endokrynol Pol; 2009; 60(3):172-9. PubMed ID: 19569017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome.
    Di Renzo L; Bertoli A; Bigioni M; Del Gobbo V; Premrov MG; Calabrese V; Di Daniele N; De Lorenzo A
    Curr Pharm Des; 2008; 14(26):2699-706. PubMed ID: 18991689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
    Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
    Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity.
    Yang X; Jansson PA; Pellmé F; Laakso M; Smith U
    Obes Res; 2005 May; 13(5):813-7. PubMed ID: 15919832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery.
    Brull DJ; Montgomery HE; Sanders J; Dhamrait S; Luong L; Rumley A; Lowe GD; Humphries SE
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1458-63. PubMed ID: 11557672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of IL-6 C-174G (rs 1800795) single nucleotide polymorphism with type 2 diabetes mellitus in Pakistani population.
    Nadeem A; Mumtaz S; Naveed AK; Mansoor Q; Aslam M; Siddiqui A; Ismail M
    J Pak Med Assoc; 2017 Mar; 67(3):428-433. PubMed ID: 28303994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 gene promoter -174G/C polymorphism and insulin resistance: a pilot study.
    Tretjakovs P; Latkovskis G; Licis N; Juhnevica D; Jurka A; Bormane I; Aivars JI; Stifts A; Pirags V
    Clin Chem Lab Med; 2007; 45(9):1145-8. PubMed ID: 17848119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
    Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.
    Testa R; Olivieri F; Bonfigli AR; Sirolla C; Boemi M; Marchegiani F; Marra M; Cenerelli S; Antonicelli R; Dolci A; Paolisso G; Franceschi C
    Diabetes Res Clin Pract; 2006 Mar; 71(3):299-305. PubMed ID: 16140413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology.
    Marso SP; House JA; Hopkins PJ
    Int J Immunogenet; 2006 Oct; 33(5):347-54. PubMed ID: 16984279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. -174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers.
    Di Renzo L; Bianchi A; Saraceno R; Calabrese V; Cornelius C; Iacopino L; Chimenti S; De Lorenzo A
    Pharmacogenet Genomics; 2012 Feb; 22(2):134-42. PubMed ID: 22158445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
    Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis.
    Zhao K; Xu J; Tian H
    Genet Mol Res; 2016 Mar; 15(1):15017021. PubMed ID: 26985948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.